Home LiteratureArticle Details
PMID: 12819970 Published · ppublish English Journal Article

Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Langenbeck's archives of surgery ·Vol. 388 ·No. 3 ·2003-07-00 ·Pages 194-200

Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hänninen E, Hintze RE

Abstract

Surgical resection provides the only chance of cure for patients suffering from hilar cholangiocarcinoma. Although appropriate procedures are not agreed upon, an increase in radicality has been observed during the past 20 years. The literature as well as our own experience after 133 resections of hilar cholangiocarcinomas were reviewed. Tumor-free margins represent the most important prognostic parameter. Hilar resections as least radical resective procedure will generate rates of formally curative resections of less than 50%. Even after these formally curative resections, long-term survival cannot be achieved. Only additional liver resections will increase the number of long-term survivors to significant figures. In our series, the best 5-year survival rate of 72% was achieved after right trisegmentectomy with concomitant resection of the portal vein bifurcation. Right trisegmentectomy and combined portal vein resection represent the best way to comply with basic rules of surgical oncology for hilar cholangiocarcinoma. This procedure will provide the most pronounced benefit among various types of liver resection, whereas local resections of the extrahepatic bile duct must be considered as an oncologically inefficient procedure.

MeSH Terms
Bile Duct Neoplasms/mortality,surgery Bile Ducts, Extrahepatic/surgery Bile Ducts, Intrahepatic Cholangiocarcinoma/mortality,surgery Hepatectomy/methods Humans Lymph Node Excision Survival Rate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Neuhaus Peter
Klinik für Allgemein-, Viszeral und Transplantationschirurgie, Charité, Campus Virchow Klinikum, Humboldt University Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. peter.neuhaus@charite.de
Jonas Sven
Settmacher Utz
Thelen Armin
Benckert Christoph
Lopez-Hänninen Enrique
Hintze Rainer E
References (24)
24 references, click to expand
  1. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Ann Surg. 2003 Feb;237(2):201-7 PMID: 12560778
  2. Clinicopathologic studies on perineural invasion of bile duct carcinoma.
    Ann Surg. 1992 Apr;215(4):344-9 PMID: 1558415
  3. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?
    Surgery. 1998 Feb;123(2):131-6 PMID: 9481397
  4. Initial experience with a new Yamakawa-type prosthesis for long-term percutaneous transhepatic drainage.
    Endoscopy. 1999 Nov;31(9):748-50 PMID: 10604619
  5. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.
    J Hepatobiliary Pancreat Surg. 2000;7(2):155-62 PMID: 10982608
  6. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9 PMID: 11573044
  7. Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization.
    Radiology. 1998 Jul;208(1):217-22 PMID: 9646816
  8. Pathological aspects of cholangiocarcinoma.
    J Pathol. 1983 Feb;139(2):217-38 PMID: 6298394
  9. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.
    Ann Surg. 1999 Nov;230(5):663-71 PMID: 10561090
  10. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
    J Gastrointest Surg. 1999 Jul-Aug;3(4):369-73 PMID: 10482688
  11. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection.
    Ann Surg. 2001 Mar;233(3):385-92 PMID: 11224627
  12. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
    Cancer. 1977 Jan;39(1):232-46 PMID: 64293
  13. Surgical treatment for carcinoma at the confluence of the major hepatic ducts.
    Surg Gynecol Obstet. 1986 May;162(5):457-64 PMID: 3704902
  14. Primary cancers of extrahepatic biliary passages.
    Int J Radiat Oncol Biol Phys. 1985 Apr;11(4):849-54 PMID: 3980281
  15. Management strategies in resection for hilar cholangiocarcinoma.
    Ann Surg. 1992 Jan;215(1):31-8 PMID: 1309988
  16. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors.
    Gastrointest Endosc. 2001 Jan;53(1):40-6 PMID: 11154487
  17. Surgical anatomy and anatomical surgery of the liver.
    World J Surg. 1982 Jan;6(1):3-9 PMID: 7090393
  18. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
    N Engl J Med. 1997 Oct 23;337(17):1188-94 PMID: 9337377
  19. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial.
    Lancet. 1982 Oct 23;2(8304):896-9 PMID: 6126752
  20. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report.
    Surgery. 1990 May;107(5):521-7 PMID: 2333592
  21. Percutaneous palliation of unresectable pancreatic cancer.
    Surg Clin North Am. 1995 Oct;75(5):989-99 PMID: 7544921
  22. Surgical treatment of hilar carcinoma of the bile duct.
    Surg Gynecol Obstet. 1986 Feb;162(2):153-8 PMID: 3945893
  23. Peripheral hepatojejunostomy as palliative treatment for irresectable malignant tumors of the liver hilum.
    Ann Surg. 1999 Feb;229(2):181-6 PMID: 10024098
  24. Extended resections for hilar cholangiocarcinoma.
    Ann Surg. 1999 Dec;230(6):808-18; discussion 819 PMID: 10615936
Article Info
Journal
Langenbeck's archives of surgery
Abbr.
Langenbecks Arch Surg
ISSN
1435-2443
Published
2003-07-00
Epub
2003-00-18
Pages
194-200
Language
English
Region
Germany
NLM ID
9808285
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com